A Novel Inhibitor of the Obesity-Related Protein FTO

被引:79
|
作者
Qiao, Yan [1 ]
Zhou, Bin [2 ,3 ]
Zhang, Meizi [4 ]
Liu, Weijia [2 ,3 ]
Han, Zhifu [2 ,3 ]
Song, Chuanjun [5 ]
Yu, Wenquan [5 ]
Yang, Qinghua [5 ]
Wang, Ruiyong [5 ]
Wang, Shaomin [5 ]
Shi, Shuai [5 ]
Zhao, Renbin [4 ]
Chai, Jijie [2 ,3 ]
Chang, Junbiao [1 ]
机构
[1] Zhengzhou Univ, Basic Med Coll, Dept Pathophysiol, Zhengzhou 450001, Peoples R China
[2] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China
[3] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China
[4] China Acad Space Technol, Engn Res Ctr Space Biol, Space Biol Res & Technol Ctr, Beijing 100190, Peoples R China
[5] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450001, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
RNA DEMETHYLASE ALKBH5; OXIDATIVE DEMETHYLATION; CRYSTAL-STRUCTURE; FAT-MASS; DNA; N-6-METHYLADENOSINE; 3-METHYLTHYMINE; RECOGNITION; METHYLATION; MECHANISM;
D O I
10.1021/acs.biochem.6b00023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fe-II and alpha-ketoglutarate-dependent fat mass and obesity associated protein (FTO)-dependent demethylation of m(6)A is important for regulation of mRNA splicing and adipogenesis. Developing FTO-specific inhibitors can help probe the biology of FTO and unravel novel therapeutic targets for treatment of obesity or obesity-associated diseases. In the present paper, we have identified that 4-chloro-6-(6'-chloro-7'-hydroxy-2',4',4'-trimethyl-chroman-2'-yl)benzene-1,3-diol (CHTB) is an inhibitor of FTO. The crystal structure of CHTB complexed with human FTO reveals that the novel small molecule binds to FTO in a specific manner. The identification of the novel small molecule offers opportunities for further development of more selective and potent FTO inhibitors.
引用
收藏
页码:1516 / 1522
页数:7
相关论文
共 50 条
  • [21] Obesity-related hormone
    Stephenson, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (11): : 1239 - 1239
  • [22] Obesity-related hypertension
    Adamczak, Marcin
    Gojowy, Damian
    Wiecek, Andrzej
    [J]. ARTERIAL HYPERTENSION, 2014, 18 (04): : 224 - 236
  • [25] Genetics of obesity and obesity-related hypertension
    Hamann, A
    Sharma, AM
    [J]. SEMINARS IN NEPHROLOGY, 2002, 22 (02) : 100 - 104
  • [26] Obesity and obesity-related comorbidities research
    Burton, D
    [J]. JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2004, 41 (04): : 641 - 641
  • [27] Perforin Is a Novel Immune Regulator of Obesity-Related Insulin Resistance
    Revelo, Xavier S.
    Tsai, Sue
    Lei, Helena
    Luck, Helen
    Ghazarian, Magar
    Tsui, Hubert
    Shi, Sally Y.
    Schroer, Stephanie
    Luk, Cynthia T.
    Lin, Gloria H. Y.
    Mak, Tak W.
    Woo, Minna
    Winer, Shawn
    Winer, Daniel A.
    [J]. DIABETES, 2015, 64 (01) : 90 - 103
  • [28] Novel Insights in the Physiopathology and Management of Obesity-Related Kidney Disease
    Sandino, Justo
    Martin-Taboada, Marina
    Medina-Gomez, Gema
    Vila-Bedmar, Rocio
    Morales, Enrique
    [J]. NUTRIENTS, 2022, 14 (19)
  • [29] Variation in the fat mass and obesity-related (FTO) genotype is not associated with body fatness in infants, but possibly with their length
    Henriksson, P.
    Lof, M.
    Soderkvist, P.
    Forsum, E.
    [J]. PEDIATRIC OBESITY, 2014, 9 (05): : E112 - E115
  • [30] PHYSICAL ACTIVITY ATTENUATES THE EFFECT OF THE FTO T/A POLYMORPHISM ON OBESITY-RELATED PHENOTYPES IN ADULT RUSSIAN MALES
    Bondareva, E. A.
    Popova, E., V
    Ketlerova, E. S.
    Kodaneva, L. N.
    Otgon, G.
    [J]. HUMAN SPORT MEDICINE, 2019, 19 (03): : 119 - 124